Apollomics, Inc. (APLM) vs Werewolf Therapeutics, Inc. (HOWL)
A side-by-side comparison of Apollomics, Inc. and Werewolf Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$22.10HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
HOWL
Werewolf Therapeutics, Inc.
$0.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — APLM vs HOWL
growth of $100 · dividends reinvested · last 5yAPLM -97.6% (-52.8%/yr)HOWL -93.8% (-42.6%/yr)HOWL compounded faster over this window
APLM HOWL
APLM vs HOWL: by the numbers
- •APLM is the larger company ($49M vs $45M market cap).
- •Both run net losses; APLM's is the smaller (-128.69% vs -164.82% net margin).
Metrics side by side
Valuation
| Metric | APLM | HOWL |
|---|---|---|
| P/S ratio | N/A | 2.13 |
| P/B ratio | N/A | 2.74 |
Profitability
| Metric | APLM | HOWL |
|---|---|---|
| Gross margin | 97.00% | 0.00% |
| Operating margin | -111.45% | 0.00% |
| Net margin | -128.69% | -164.82% |
| ROE | N/A | -212.45% |
| ROIC | -2441.49% | -156.97% |
Growth (annualized)
| Metric | APLM | HOWL |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | N/A |
| Total return CAGR (5Y) | N/A | -44.27% |
Go deeper
Dig into the metrics
Apollomics ROEWerewolf Therapeutics ROEApollomics operating marginWerewolf Therapeutics operating marginApollomics revenue growthWerewolf Therapeutics revenue growthApollomics free cash flowWerewolf Therapeutics free cash flow
Apollomics & Werewolf Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.